TRANSCODE THERAPEUTICS INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
TRANSCODE THERAPEUTICS INC. - More news...
TRANSCODE THERAPEUTICS INC. - More news...
- TransCode Therapeutics Announces FDA Authorization to Proceed with First-In-Human Clinical Trial
- TransCode Therapeutics Announces Withdrawal of Registration Statement
- TransCode Therapeutics Announces eIND Submission to US FDA for Planned First-in-Human Clinical Trial in Patients with Advanced Solid Tumors
- TransCode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update
- TransCode Therapeutics Reports Positive Preclinical Results with its Lead Candidate, TTX-MC138, in Pancreatic Adenocarcinoma
- TransCode Therapeutics Announces Publication of Feline Case Study in Frontiers in Oncology
- TransCode Therapeutics to Participate at the Chardan 6th Annual Genetic Medicines Conference
- TransCode Therapeutics Appoints MicroRNA Pioneer, Dr. Frank Slack, to its Advisory Board
- TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update
- TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology
- TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio
- TransCode Therapeutics to Participate at BIO International Convention
- TransCode Therapeutics Receives National Institutes of Health (NIH) Notice of Award
- TransCode Therapeutics To Participate at H.C. Wainwright Global Investment Conference
- TransCode Therapeutics Acquires Option for Radiotheranostic Technology
- TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
- TransCode Therapeutics Reports 2021 Results; Provides Business Update
- TransCode Therapeutics Interview to Air on Bloomberg U.S. on the RedChip Money Report®
- TransCode Therapeutics Announces Article Published in the Journal Cancers Detailing the Potential for Short RNA-based Drugs in Cancer and a Broad Range of Disorders
- TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio
- CORRECTION --TransCode Therapeutics
- TransCode Therapeutics to Present at 2020 BIO CEO & INVESTOR CONFERENCE
- TransCode Therapeutics To Participate at H.C. Wainwright BioConnect Conference
- TransCode Therapeutics To Participate at MedInvest Oncology Investor Conference
- TransCode Therapeutics Announces Participation in the Q4 Virtual Investor Summit